Currently, the mechanisms of endocrine therapy resistance in breast cancer have been found to include estrogen receptor gene abnormalities (4), deregulated activation of cell signaling pathways (5), epigenetic regulation (6), alteration of cell cycle regulation (7), and the existence of tumor stem cell-like cells (8). The gene discussed is ESR1; the disease is breast carcinoma.